OTC Medicines

Browse OTC Medicines Content

CHPA applauds FDA for taking a critical step forward today in public health, which will remove many of the barriers and stigmas attached to this life-saving emergency therapy for opioid overdoses

Mar 29, 2023

Good science, and new customer behavior mean the time is right for companies to evaluate their portfolios to position themselves for success. Tailwinds are good, private equity interest is high, and the self-care future is bright.

Mar 13, 2023

CHPA tracks FDA progress vs. OMUFA goals and activities referenced in legislation. These goals were negotiated between the Agency and Industry prior to the legislation and cover the 5-year period for OMUFA I (October 1, 2020 – September 30, 2025).

Mar 9, 2023

The Consumer Healthcare Products Association’s (CHPA) Educational Foundation today announced the launch of HealthInHand.org

Mar 1, 2023

The Consumer Healthcare Products Association (CHPA) released the following statement in advance of FDA Advisory Committee meetings considering OTC access to naloxone

Feb 15, 2023

The purpose of this cybersecurity and data privacy regulatory scan is to understand the current and forthcoming regulatory landscape related to cybersecurity and consumer data privacy.

Jan 20, 2023

Don't miss CHPA President & CEO, Scott Melville's insights on the consumer healthcare industry for the year ahead. Check out this article from Chain Drug Review.

Jan 9, 2023

CHPA applauds the passage of the Fiscal Year 2023 omnibus appropriations bill, which includes several CHPA-backed measures.

Dec 23, 2022

Filter Results